SARS-CoV-2 Seroprevalence study in three African countries

The SeroCoV study is a household-based cross-sectional study that aims to estimate the prevalence of anti-SARS-CoV-2 IgG antibodies and associated risk factors in three African countries: Burkina Faso, Ghana, and Madagascar. Commmunity members from altogether 5 urban sites that are 10 years or older are recruited using using a two-stage cluster sampling approach. The primary outcome measure is the proportion of the population that has been exposed to the virus and have developed anti SARS-CoV-2 antibodies; measured by Enzyme-linked Immunosorbent Assays (ELISAs).


Partner country Burkina Faso
Institutions Centre de Recherche en Santé de Nouna
Partner country Ghana
Institutions Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)
Partner country Madagascar
Institutions Faculté de Medicine, Université de Fianatantsoa
Partner country Germany
Institutions University of Heidelberg


Teams at partner institutions:

Team Hamburg: Eva Lorenz, Christina Deschermeier, Ben Rushton, Jenny Kettenbeil, Wibke Loag.            

Team Burkina Faso: Aurélia Souares, Ali Sié, Thierry Ouedraogo, Valentin Buodo.                                   

Team Ghana: John Amuasi, Anthony Afum-Adjei Awuah, Christian Obirikorang.                                      

Team Madagascar: Daniela Fusco, Rivo Rakotoarivelo, Dominik Benke, Yannick Hoeppner


Funding Period 2020-2021
Funding Body German Ministry of Health (BMG)

Department of Infectious Disease Epidemiology

Porträtfoto von Prof. Dr. Jürgen May, eines erfahrenen freundlich blickenden Forschers
Head of Dept Infectious Diseases Epidemiology

Prof. Dr. Jürgen May

Telefon: +49 40 285380-402


  • Logo DZIF